ATI pharmacology exam 2. Questions and Answers 2025
1. The central nervous system (CNS) cells, where the impulses for the
sympathetic nervous system (SNS) originate, are located where?
A. Hypothalamus and the medulla
B. Cranium and sacral area of the spinal cord
C. Thoracic and lumbar section of the spinal cord
D. Nerve membrane
2. A patient who has Parkinson disease is being treated with the
anticholinergic medication benztropine (Cogentin). The nurse will tell the
patient that this drug will have which effect?
A. Reducing some of the tremors
B. Improving mental function
C. Helping the patient to walk faster
D. Minimizing symptoms of bradykinesia
3. The nurse administers a drug to a patient whose heart rate is bradycardic
aimed at increasing heart rate and myocardial activity. What adrenergic
receptor is this drug stimulating?
A. Beta 1
B. Beta 2
C. Alpha 2
D. Alpha 1
4. The nurse assess that the patient is having a sympathetic response when
noting what manifestation?
A. Decrease in heart rate and perfusion, and an increase in inflammatory response
B. Increase motility and secretion in the GI tract, constriction of bronchi and pupils
C. Increase in blood pressure, bronchodilation, and decrease bowel sounds
D. Decrease in sweating, decrease in respiration, and pupil constriction
5. A patient who has been diagnosed with depression asks why the provider
has not ordered a monoamine oxidase (MAO) inhibitor to treat the disorder.
The nurse will explain to the patient that MAO inhibitors
A. are no longer approved for treating depression.
B. are more expensive than other antidepressants.
C. require strict dietary restrictions.
D. can cause profound hypotension.
, ATI pharmacology exam 2. Questions and Answers 2025
6. A client primary care provider prescribed a B-adrenergic receptor blocker.
Which of the following therapeutic effects do the client and care provider
likely seek?
A. Increase in mental acuity
B. Slowing of gastrointestinal motility
C. Decreased production in gastric acid
D. Reduction in the heart rate and blood pressure
7. The nurse is preparing to administer a first dose of benztropine (Cogentin)
to a patient diagnosed with parkinsonism. The nurse would notify the
patient’s provider if the patient had a history of which condition?
A. Irritable bowel disease
B. Glaucoma
C. Asthma
D. Hypertension
8. Identify one indicator for a narcotic antagonist to be prescribed?
A. Reversal of bronchoconstriction
B. Reversal of tachycardia
C. Treatment of alcohol independence
D. Treatment of narcotic dependence
9. How does ephedrine act on the body?
A. Acts directly on alpha-Adrenergic receptor sites
B. Stimulates the release of norepinephrine
C. Acts directly on Beta-Adrenergic receptor sites
D. Stimulates the release of Dopamine
10.A patient is being admitted to the floor following a motor vehicle accident.
because of the stressful nature of the event, the nurse anticipates the
patient will continue to have a sympathetic reaction during the post
operative period. When monitoring the patient's serum electrolytes, what
will the nurse closely monitor?
A. Increased calcium
B. Deceased sodium
1. The central nervous system (CNS) cells, where the impulses for the
sympathetic nervous system (SNS) originate, are located where?
A. Hypothalamus and the medulla
B. Cranium and sacral area of the spinal cord
C. Thoracic and lumbar section of the spinal cord
D. Nerve membrane
2. A patient who has Parkinson disease is being treated with the
anticholinergic medication benztropine (Cogentin). The nurse will tell the
patient that this drug will have which effect?
A. Reducing some of the tremors
B. Improving mental function
C. Helping the patient to walk faster
D. Minimizing symptoms of bradykinesia
3. The nurse administers a drug to a patient whose heart rate is bradycardic
aimed at increasing heart rate and myocardial activity. What adrenergic
receptor is this drug stimulating?
A. Beta 1
B. Beta 2
C. Alpha 2
D. Alpha 1
4. The nurse assess that the patient is having a sympathetic response when
noting what manifestation?
A. Decrease in heart rate and perfusion, and an increase in inflammatory response
B. Increase motility and secretion in the GI tract, constriction of bronchi and pupils
C. Increase in blood pressure, bronchodilation, and decrease bowel sounds
D. Decrease in sweating, decrease in respiration, and pupil constriction
5. A patient who has been diagnosed with depression asks why the provider
has not ordered a monoamine oxidase (MAO) inhibitor to treat the disorder.
The nurse will explain to the patient that MAO inhibitors
A. are no longer approved for treating depression.
B. are more expensive than other antidepressants.
C. require strict dietary restrictions.
D. can cause profound hypotension.
, ATI pharmacology exam 2. Questions and Answers 2025
6. A client primary care provider prescribed a B-adrenergic receptor blocker.
Which of the following therapeutic effects do the client and care provider
likely seek?
A. Increase in mental acuity
B. Slowing of gastrointestinal motility
C. Decreased production in gastric acid
D. Reduction in the heart rate and blood pressure
7. The nurse is preparing to administer a first dose of benztropine (Cogentin)
to a patient diagnosed with parkinsonism. The nurse would notify the
patient’s provider if the patient had a history of which condition?
A. Irritable bowel disease
B. Glaucoma
C. Asthma
D. Hypertension
8. Identify one indicator for a narcotic antagonist to be prescribed?
A. Reversal of bronchoconstriction
B. Reversal of tachycardia
C. Treatment of alcohol independence
D. Treatment of narcotic dependence
9. How does ephedrine act on the body?
A. Acts directly on alpha-Adrenergic receptor sites
B. Stimulates the release of norepinephrine
C. Acts directly on Beta-Adrenergic receptor sites
D. Stimulates the release of Dopamine
10.A patient is being admitted to the floor following a motor vehicle accident.
because of the stressful nature of the event, the nurse anticipates the
patient will continue to have a sympathetic reaction during the post
operative period. When monitoring the patient's serum electrolytes, what
will the nurse closely monitor?
A. Increased calcium
B. Deceased sodium
